Table 5.
Adjusted logistic regression models with stepwise models including demographics in model 1, tumor characteristics in model 2, and dual enrollment in model 3
Model 1 Adjusted for demographics |
Model 2 Additional adjustment for tumor characteristics |
Model 3 Additional adjustment for dual enrollment |
|||||||
---|---|---|---|---|---|---|---|---|---|
Characteristic | OR | 95% CI | P value* | OR | 95% CI | P value* | OR | 95% CI | P value* |
Redlining category | <.001* | <.001* | .0091* | ||||||
Low | — | — | — | — | — | — | |||
Moderate | 0.93 | 0.89, 0.99 | .0111 | 0.96 | 0.91, 1.02 | .1264 | 0.98 | 0.93, 1.04 | .5042 |
High | 0.82 | 0.76, 0.88 | <.001 | 0.85 | 0.79, 0.91 | <.001 | 0.89 | 0.82, 0.95 | .0022 |
Moderate vs high† | <.001 | <.001 | .0085 | ||||||
SEER Race/Ethnicity | <.001* | <.001* | <.001* | ||||||
NH White | — | — | — | — | — | — | |||
NH Black | 0.66 | 0.61, 0.72 | <.001 | 0.71 | 0.66, 0.78 | <.001 | 0.78 | 0.71, 0.84 | <.001 |
NH Asian | 0.98 | 0.81, 1.14 | .7642 | 0.98 | 0.81, 1.12 | .7816 | 1.09 | 0.92, 1.24 | .2296 |
Hispanic | 0.91 | 0.79, 1.03 | .1931 | 0.96 | 0.85, 1.08 | .4804 | 1.09 | 0.96, 1.25 | .2072 |
NH Black vs NH Asian† | <.001 | <.001 | <.001 | ||||||
SEER-Medicare age group | <.001‡ | <.001‡ | <.001‡ | ||||||
66-70 y | — | — | — | — | — | — | |||
71-75 y | 1.14 | 1.08, 1.23 | <.001 | 1.13 | 1.06, 1.22 | <.001 | 1.13 | 1.06, 1.21 | <.001 |
76-80 y | 0.82 | 0.76, 0.87 | <.001 | 0.82 | 0.76, 0.87 | <.001 | 0.82 | 0.77, 0.87 | <.001 |
81-85 y | 0.47 | 0.42, 0.51 | <.001 | 0.48 | 0.43, 0.53 | <.001 | 0.48 | 0.43, 0.53 | <.001 |
86-90 y | 0.20 | 0.18, 0.22 | <.001 | 0.22 | 0.19, 0.24 | <.001 | 0.22 | 0.19, 0.24 | <.001 |
71-75 vs 86-90 y† | <.001 | <.001 | <.001 | ||||||
Dual enrollment | <.001‡ | ||||||||
No | — | — | |||||||
Yes | 0.64 | 0.58, 0.71 | <.001 |
Abbreviations: OR = odds ratio; SEER = Surveillance, Epidemiology, and End Results.
Obtained from generalized linear regression model with cluster bootstrap.
Comparison of nonreferent groups with highest discrepancy between ORs was added as post hoc analysis.
Global P value.
Model also adjusted for comorbidities, stage, breast receptor subtype, census region, and year of diagnosis.